Clinical Trials Directory

Trials / Sponsors / Illumina, Inc.

Illumina, Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingCardioSeq: Impact of WGS in Individuals With CVD
Cardiovascular Diseases
N/A2023-01-06
Active Not RecruitingiKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders
Genetic Disease
—2021-11-09
CompletedEvaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
SARS-CoV-2
—2020-09-11
CompletedEvaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel
SARS-CoV-2
—2020-02-13
CompletedNeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neuro
Neurologic Deficits, Neurologic Disorder, Neurologic Abnormalities
—2019-11-18
CompletedA Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
Pregnancy
—2018-05-21
CompletedNICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard
Rare Diseases
N/A2017-09-14
CompletedCollection of Whole Blood Specimens in Pregnant Women
Pregnancy Related
—2017-02-13
CompletedDevelopment of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
Preeclampsia
—2016-03-01
CompletedSingle Embryo TrAnsfeR of Euploid Embryo
Infertility, Aneuploidy
N/A2014-09-01
CompletedMethod Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Post-natal Cytogenetics
—2011-08-01
CompletedDetection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA
Detection and Genotyping of Factor V and Factor II Point Mutations
—2009-08-01